Sintx Technologies announces exploration of potential strategic options

SINTX Technologies announced that its Board of Directors has initiated a process to explore potential strategic options for the Company. SINTX has multiple business lines focused on technical materials, with manufacturing and R&D sites located in Salt Lake City and Millersville, MD. In addition to its FDA-approved silicon nitride ceramic spinal fusion devices, the Company has developed ceramic-polymer composites, a novel technology that addresses other medical devices, such as implants for lower extremity fusion. Based on extensive peer-reviewed published data, the key advantages of the Company’s proprietary medical-grade silicon nitride include its proven biocompatibility, inherent resistance to bacteria and viruses, bone cell stimulation, and ease of radiographic imaging. More recently, the Company’s femoral head technology has attracted renewed interest from several global partners. The Company’s silicon nitride is also being utilized in several aerospace engine applications, with two long-term supply agreements in this market…There can be no assurance that the strategic process will result in the Company pursuing any particular transaction or outcome. The SINTX Board has not set a timetable for completion of this process, and it will not disclose further developments until such time that the Company determines that further disclosure is appropriate or necessary.